Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ProKidney Corp. - Class A Ordinary Shares (NQ:PROK)

1.860 -0.040 (-2.11%)
Streaming Delayed Price Updated: 2:11 PM EDT, Apr 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ProKidney Corp. - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
3 Biotech Stocks Due for a Massive Short Squeeze ↗
These are the biotech short squeeze candidates to buy and hold for a massive rally of up to 100% in the coming quarters. 
Via InvestorPlace
News headline image
ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights
From ProKidney
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023 ↗
 
Via Benzinga
News headline image
ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC
From ProKidney
Via GlobeNewswire
News headline image
ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization
From ProKidney
Via GlobeNewswire
News headline image
Affirm Holdings, Applied Digital And Other Big Stocks Moving Lower On Thursday ↗
U.S. stocks traded lower, with the Dow Jones dropping more than 450 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC
From ProKidney
Via GlobeNewswire
News headline image
ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference
From ProKidney
Via GlobeNewswire
News headline image
ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights
From ProKidney
Via GlobeNewswire
News headline image
ProKidney to Present at the BofA Securities Health Care Conference 2023
From ProKidney
Via GlobeNewswire
News headline image
ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights
From ProKidney
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the... 
Via Benzinga
News headline image
ProKidney to Participate in TD Cowen’s 43rd Annual Health Care Conference
From ProKidney
Via GlobeNewswire
News headline image
Teradata, Monday.Com And Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Why Lightning eMotors Shares Are Trading Lower By 9%; Here Are 20 Stocks Moving Premarket ↗
Gainers Broadwind, Inc. (NASDAQ: BWEN) rose 68.1% to $3.80 in pre-market trading after the company reported transformational two-year, $175 million wind tower order with global wind turbine... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
It's time to start off the day with a breakdown of the biggest pre-market stock movers making the news on Wednesday morning! 
Via InvestorPlace
News headline image
World Wrestling Entertainment, Bed Bath & Beyond And Some Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney Disease
From ProKidney
Via GlobeNewswire
News headline image
CinCor Pharma, Anavex Life Sciences And Some Other Big Stocks Moving Lower On Monday ↗
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. 
Via Benzinga
News headline image
ProKidney Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
From ProKidney
Via GlobeNewswire
News headline image
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal... 
Via Benzinga
News headline image
ProKidney to Participate in Upcoming Investor Conferences
From ProKidney
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 258 companies hit new 52-week lows. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022 ↗
 
Via Benzinga
News headline image
ProKidney Receives Allowance from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for proact 1 (REGEN-006) and EMA Scientific Advice on Phase 3 Protocols of REACT for Diabetic Chronic Kidney Disease
From ProKidney
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.